CBB1007 is primarily utilized in the field of biomedical research, particularly in the study of cancer therapeutics. It is known for its role as a potent inhibitor of specific protein kinases that are involved in cell signaling pathways associated with tumor growth and proliferation. Researchers employ CBB1007 to investigate its potential in disrupting these pathways, thereby inhibiting cancer cell survival and metastasis. Its application extends to preclinical studies where it is used to evaluate efficacy, safety, and mechanisms of action in various cancer models. Additionally, CBB1007 serves as a valuable tool in understanding the molecular basis of kinase-related diseases and in the development of targeted therapies.